Investing.com -- Federal Reserve Bank of Atlanta President Raphael Bostic stressed the importance of maintaining restrictive interest rates to bring inflation back to the central bank’s 2% target.

Investing.com -- The agribusiness and protein sector is positioning for a potential rebound with several companies standing out in BMO’s latest analysis. These industry leaders are leveraging ...

This resulted in analysts at UBS lifting its Eurozone GDP growth forecast for 2026 by 0.2 percentage points to 1.3%, while keeping 2027 and 2028 forecasts unchanged at 1.4% and 1%, respectively. The ...

The European Union plans to propose the use of "trusted semiconductors" in drone systems as part of a new strategy aimed at increasing drone production for civilian and defense purposes. The proposal, ...

Investing.com -- Canada Goose Holdings Inc (NYSE:GOOS) was hit with multiple downgrades after missing third-quarter profit estimates, as higher marketing and promotional spending weighed on margins ...

Investing.com -- Chinese artificial intelligence development has accelerated at a remarkable pace, with progress over the ...

Investing.com -- Addentax Group Corp (NASDAQ:ATXG) stock surged 38% in premarket trade Friday after the company announced plans to acquire the offshore wealth management and integrated cross-border ...

Investing.com -- A German court has ordered Renault to stop selling its Megane and Clio models due to a patent rights dispute with U.S. technology group Broadcom, according to business magazine ...

Investing.com-- Bitcoin rebounded from a 16-month low in Asian trade on Friday but was headed for a deep weekly decline as a broader risk-off mood, amid uncertainty over U.S. monetary policy, battered ...

Investing.com -- UiPath Inc (NYSE:PATH) stock rose 2.5% in premarket trading Friday after the automation software company announced the acquisition of WorkFusion, a specialist in AI agents for ...

Investing.com -- Iranian Foreign Minister Abbas Araghchi said talks with the United States had a "good start" after multiple rounds of meetings on Friday. "Several rounds of meetings were held today.

Investing.com -- Roivant Sciences (NASDAQ:ROIV) stock surged 15% after reporting positive Phase 2 results for brepocitinib in ...